Biodesy is developing the first products and systems to rapidly and inexpensively measure both protein structure and function in real time, with applications including drug discovery, structural biology and clinical biomarkers. Biodesy has developed a unique and highly sensitive technology for detecting conformational change in proteins and other biological molecules. Our technology, based on a phenomenon called second-harmonic generation, can monitor structural changes at any site within a protein, in real time. Since protein function is determined by its structure, and changes in structure cause changes in function, characterizing these changes will provide significant insights into how our bodies function and respond to treatments.
Biodesy, Inc. was founded in 2013, based on technology and intellectual property developed in 2000. Our investors include 5AM Ventures, Pfizer Ventures, and Roche Venture Fund. Our headquarters are located in South San Francisco, California.